Results 151 to 160 of about 197,879 (225)

Editorial: The magic bullet evolution in tumor therapy: novel drug conjugates for targeted delivery. [PDF]

Front Pharmacol
Gazzola S, Neundorf I, Sewald N.
europepmc   +1 more source

Recent Advances in PBAT (Nano) Composite Materials for Food Packaging: A Comprehensive Review

Journal of Applied Polymer Science, EarlyView.
Poly(butylene adipate‐co‐terephthalate) (PBAT) is the most commonly used plastic. PBAT‐based (nano) composites provide a lot of potential as food wrapping. The preparation of plastics based on PBAT composites is described. PBAT materials' distinctive properties lead to suitability for application in food packaging.
Raja Venkatesan, Vishnuvarthanan Mayakrishnan, Maher M. Alrashed, Seong‐Cheol Kim   +3 more
wiley   +1 more source

Controlling the Crystallization Kinetics of Low Loss Phase Change Material Sb2S3

Advanced Physics Research, EarlyView.
This paper explores the glass dynamics and crystallization kinetics of antimony sulfide (Sb2S3), and its implications for optoelectronic technologies. It highlights how adjusting sample dimensions influences crystallization kinetics, shifting from growth‐driven to nucleation‐driven processes. The findings emphasize the importance of understanding these
Felix Hoff, Julian Pries, Jan Köttgen, Pierre Lucas, Matthias Wuttig   +4 more
wiley   +1 more source

Production of site-specific antibody conjugates using metabolic glycoengineering and novel Fc glycovariants. [PDF]

J Biol Chem
Bernstein ZJ, Gierke TR, Dammen-Brower K, Tzeng SY, Zhu S, Chen SS, Wilson DS, Green JJ, Yarema KJ, Spangler JB.   +9 more
europepmc   +1 more source

Respiratory syncytial virus-approved mAb Palivizumab as ligand for anti-idiotype nanobody-based synthetic cytokine receptors. [PDF]

J Biol Chem, 2023
Ettich J, Wittich C, Moll JM, Behnke K, Floss DM, Reiners J, Christmann A, Lang PA, Smits SHJ, Kolmar H, Scheller J.   +10 more
europepmc   +1 more source

Tuning Reactivity in Cu/TEMPO Catalyzed Alcohol Oxidation Reactions

Chemistry – An Asian Journal, EarlyView.
Novel copper(I) complexes bearing a secondary amine moiety (CuL3) or an additional non‐innocent functionality with intact imine group (Cu2L42) were synthesized and tested towards oxidation reactions. Several intermediates, such as Cu(III)2(bis‐μ‐oxo) and Cu(II)2(bis‐μ‐hydroxo), species were trapped and spectroscopically characterized.
Maximilian Schütze, Matthias Jux, Beatrice Cula, Michael Haumann, Sagie Katz, Peter Hildebrandt, Holger Dau, Kallol Ray   +7 more
wiley   +1 more source

TNX-1500, a crystallizable fragment-modified anti-CD154 antibody, prolongs nonhuman primate renal allograft survival. [PDF]

Am J Transplant, 2023
Lassiter G, Otsuka R, Hirose T, Rosales I, Karadagi A, Tomosugi T, Dehnadi A, Lee H, Colvin RB, Baardsnes J, Moraitis A, Smith EE, Ali Z, Berhe P, Mulder A, Meibohm B, Daugherty B, Fogarty S, Pierson RN, Lederman S, Kawai T.   +20 more
europepmc   +1 more source

Crafting agency in a host community: Accessing and participating in the English higher education sector by Ukrainian refugees

British Educational Research Journal, EarlyView.
Abstract Following Russia's launch of a full‐scale war against Ukraine in 2022, scholarship has not yet addressed how Ukrainian refugees in England have been navigating the challenges of developing their agency in pursuing opportunities to participate in the higher education (HE) sector.
Iryna Kushnir, Ellis Richards
wiley   +1 more source

Engineering antibodies with cancer‐associated binding sites

BMEMat, EarlyView.
This review describes antibodies that perform direct/indirect roles in cancer treatment by binding to effective targets and discusses how antibodies kill tumors and modulate tumor microenvironment through these targets. The classification of expression systems for antibody production is summarized to guide appropriate selection based on different ...
Yinqi Tian, Yumeng Pan, Yingchun Zhang, Fangling Wang, Zejun Wang   +4 more
wiley   +1 more source

Structural insights into epitope-paratope interactions of a monoclonal antibody targeting CEACAM5-expressing tumors. [PDF]

Nat Commun
Kumar A, Duffieux F, Gagnaire M, Rapisarda C, Bertrand T, Rak A.   +5 more
europepmc   +1 more source